A single arm phase II trial of trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma cancer who are ctDNA and HER2 positive: DECIPHER.

Authors: Elizabeth Catherine Smyth, Daniel Griffiths, Kelly Cozens, Richard C. Turkington, Rajarshi Roy, Sarah Ngan, Richard Owen, Kieran Foley, Robert Waugh, Ceri Steele, Dave Chuter, Chris Hurt, Gareth Owen Griffiths

Published: 2025-01-27

DOI: 10.1200/jco.2025.43.4_suppl.tps512

Source: Full article

---

Abstract

TPS512